SpotitEarly (Series A)

Funding Details
Awarder
Inbox
Date Award
May 15, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Founding Year
2020
Traction
The breath test has demonstrated 94% accuracy in detecting multiple cancer types in a large-scale clinical trial of 1,200 people.
Company Description
SpotitEarly is a cancer-treatment-focused Israeli medtech startup.
Market
Cancer Detection
Location
United States

Links
Back to Home Back to Biotechnology Deals View Funding Announcement